Acute-on-chronic liver failure (Acute-on-chronic liver failure, ACLF) is acute liver function decompensation on the basis of chronic liver disease. The progression of ACLF develops from advanced phase, plateau phase to remission phase. The pathophysiological basis of ACLF in different phases is various. In advanced phase, immune imbalance and systemic inflammatory reaction plays key roles. In this study, we try to assess the association between expression of NK cells and its receptors and prognosis of patients with ACLF in advanced phase. A total of 35 inpatients with HBV acute-on-chronic liver failure in advanced phase were recruited. They were divided into case group (n = 18) and control group (n = 17) according to whether the patients was dead in the 12 weeks. PBMC were detected for the frequency and expression of NK cell receptors by flow cytometric analysis. Our results demonstrated that patients who died had lower expression of NK cells and inhibitory receptor KIR3DL1, higher levels of FASL. During 12-week follow-up in those case alive, we found that NK cells increased, while expression of FASL decreased. High short-term mortality of ALCF was associated with NK cell, especially related to KIR3DL1 and FASL (P NK = 0.036, P KIR3DL1 = 0.0265, P FasL = 0.0008).
. In China, the most common cause for liver failure is hepatitis B virus infection. The progression of ACLF can be divided into several stages: advanced phase, plateau phase and remission phase. In different phase, patients undergo various pathophysiology [2] . In advanced phase, immune damage and hypoxic-ischemic damage may be dominant [3] .
Currently, no criteria are available for the precise definition of different phases. According to whether their total bilirubin within 7 days of average daily rise is ≥17.1 umol/L or not, we differentiated patients with ACLF into advanced phase and not-advanced phase.
NK cells are important immune cells which are closely related to antitumor, antiviral and immune regulation in vivo [4] [5] . In the early stage of acute HBV infection, the cytotoxicity of NK cells increases, IL-2 levels rise, both play the clearance of the virus. In chronic hepatitis B, cirrhosis, hepatocellular carcinoma patients, the number and activity of NK cells were suppressed [6] . The persistence of HBV may be associated with viral suppression of NK cell as the representative of the innate immune system.
In this study, we try to assess the association between expression of NK cells and its receptors and prognosis of patients with ACLF in advanced phase. Dynamic observation of immunological characterization of natural killer cell was tested in those case alive.
Materials and Methods

Study Participants
This study was a retrospective research. All patients were hospitalized in The Third Affiliated Hospital of Sun Yat-Sen University, a large tertiary comprehensive hospital with discharged patients more than forty thousand per year. A total of 35 inpatients with HBV related acute-on-chronic liver failure (HBV-ACLF)
were recruited from October 2010 to September 2012 from our department. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The diagnoses of chronic hepatitis B and liver failure were based on consensus recommendations of APASL 2009 [7] . All patients' total bilirubin within 7 days of average daily rise is ≥17.1 umol/L. Patients were excluded if they had some special conditions such as concomitant autoimmune diseases, important organ dysfunctions not due to ACLF malignancies, pregnancy and lactation, excessive alcohol drinking within 6 months.
They were divided into case group (n = 18) and control group (n = 17) according to whether the patients was dead in the 12 weeks follow-up. 
Flow Cytometric Analysis
Peripheral blood mononuclear cells (PBMC) were isolated from fresh hepari- 
Statistical Analysis
All data were analyzed using Windows software SPSS version 20.0. Data of clinical and biochemical features were expressed as frequency and mean ± standard 
Result
Lower Levels of NK Cells and Inhibitory Receptor KIR3DL1 in Case Group
The comparison of NK cells showed lower levels in case group compared to control group (Z = 26, P = 0.036). There were no markedly differences between case group and control group, after comparison of activating NK receptors NKG2D, NKp30, NKp46 (P > 0.05). But the percentage of inhibitory NK receptor KIR3DL1 in case group was lower than in control group (Z = 17, P = 0.0265).
Other inhibitory NK receptors NKG2A, KIR2DL1, KIR2DL3 had no significant differences (P > 0.05; Figure 1 ).
Higher Levels of FASL in Case Group
The expression of FASL in case group was much higher than that in control group (Z = 0.00, P = 0.0008). Significant deviations were not observed in Perforin and Granzyme B (P > 0.05; Figure 2 ).
Increased NK Cells Expression during 12-Week Follow-up in Control Group
Dynamic observation of immunological characterization of NK cells in case 
Discussion
The progression of ACLF can be divided into several stages: advanced phase, plateau phase, and remission phase. The pathophysiological basis of ACLF in different stages is various. Immune imbalance and systemic inflammatory reaction plays a key role in the development of liver failure. Immune damage may be dominant in early advanced phase, then hypoxic-ischemic damage and endotoxin begin to take effect [8] . During the progress of ACLF, immunosuppression played a major role in plateau phase. When it comes to remission phase, immune reconstruction and rebalance begin to work [9] . According to whether their total bilirubin within 7 days of average daily rise is ≥17.1 μmol/L, we diffe- 
Conclusions
In summary, results from this study demonstrated that prognosis of patients with ACLF in advanced group had higher expression of NK associated immu- 
